Over the course of 2020, updates were presented of several pivotal randomised controlled trials in renal cell carcinoma (RCC). During the 2020 annual BMUC meeting, Prof. Dr. Axel Bex (UCL Division of Surgery and Interventional Science, London, UK. The Netherlands Cancer Institute, Amsterdam, The Netherlands) provided an overview of the most important novelties in the field of RCC and gave us a look into the future.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
